Katie Jennings is a senior writer at Forbes covering healthcare, technology and AI and a co-author of the InnovationRX newsletter. She joined Forbes in 2020 and is based in Jersey City.
for opioid and alcohol use disorder, as well as co-occurring conditions, in three states: Oregon, Washington and Ohio. Around 11,000 patients in the program get access to peer recovery specialists, clinicians and medication-assisted treatment, like buprenorphine. With $35 million inannounced Wednesday, Strong hopes to be in 10 states by 2026.
Shares of Hims, known for providing cheap and generic alternatives to popular brand-name drugs, have nearly doubled in price since the start of the year hitting $18.60 after the company announced a weight-loss treatment starting at $199 a month that will compete with Novo Nordisk’s Wegovy and Ozempic.a frozen food brand specifically aimed at people taking GLP-1 drugs like Ozempic and Wegovy in a bid to offset potential sales losses.
Ai Addiction Telehealth Medicaid Opioid Artificial Intelligence
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
President Biden’s Latest Attack On The Economy: Smother The InternetSteve Forbes is Chairman and Editor-in-Chief of Forbes Media.
Read more »
Biden Wants To Take Your CarSteve Forbes is Chairman and Editor-in-Chief of Forbes Media.
Read more »
InnovationRx: Deepmind Unveils Its New Protein-Folding AI Model AlphaFold 3I'm a senior writer at Forbes covering healthcare technology, and I also write the InnovationRX newsletter. I was previously a healthcare reporter for POLITICO covering the European Union from Brussels and the New Jersey Statehouse from Trenton. I was a 2019-2020 Knight-Bagehot Fellow in business and economics reporting at Columbia University.
Read more »
InnovationRx: Battle Of The AI Medical ScribesAlex Knapp is a senior editor at Forbes covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.
Read more »
InnovationRx: FDA Approves Abbott’s Dissolvable StentsI'm a senior editor at Forbes covering healthcare, science, and cutting edge technology. I also co-author the InnovationRX newsletter.
Read more »
InnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics StartupI'm a senior writer at Forbes covering healthcare technology, and I also write the InnovationRX newsletter. I was previously a healthcare reporter for POLITICO covering the European Union from Brussels and the New Jersey Statehouse from Trenton. I was a 2019-2020 Knight-Bagehot Fellow in business and economics reporting at Columbia University.
Read more »